| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | 1,4 M € | +0.2% | 1,4 M € | — | — | — | — | — | 1,1 M € | — | ||||||||||||||||||
| Gross margin | 142,3 k € | -14.0% | 165,5 k € | -7.3% | 178,4 k € | -13.2% | 205,5 k € | -12.5% | 234,9 k € | +5.9% | 221,9 k € | -7.4% | 239,7 k € | -6.7% | 256,8 k € | -6.5% | 274,8 k € | -5.0% | 289,3 k € | -4.0% | 301,3 k € | +13.6% | 265,3 k € | -2.8% | 272,9 k € | +1.8% | 268,2 k € | +80.4% | 148,6 k € | -31.8% | 217,9 k € | +45.0% | 150,2 k € | -20.4% | 188,6 k € | +49.4% | 126,3 k € | |
| EBITDA | -44,8 k € | -379.2% | -9,3 k € | -119.1% | 49,0 k € | -32.1% | 72,2 k € | -34.2% | 109,6 k € | +61.1% | 68,0 k € | -27.6% | 94,0 k € | -36.1% | 147,1 k € | -13.0% | 169,2 k € | -0.9% | 170,7 k € | -9.1% | 187,8 k € | +13.5% | 165,5 k € | -3.3% | 171,1 k € | -0.3% | 171,5 k € | +213.6% | 54,7 k € | -55.5% | 122,8 k € | +130.9% | 53,2 k € | -45.0% | 96,6 k € | +203.3% | 31,8 k € | |
| Operating profit | -94,4 k € | -27.4% | -74,0 k € | -426.5% | 22,7 k € | -50.7% | 46,0 k € | -44.9% | 83,5 k € | +697.8% | -14,0 k € | -118.0% | 77,4 k € | -40.9% | 131,0 k € | -15.1% | 154,3 k € | -1.9% | 157,3 k € | -9.3% | 173,5 k € | +14.2% | 151,9 k € | +32.7% | 114,5 k € | +12.4% | 101,8 k € | +556.3% | -22,3 k € | -148.6% | 45,9 k € | +285.8% | -24,7 k € | -206.8% | 23,2 k € | +158.2% | -39,8 k € | |
| Profit/loss | -83,9 k € | -48.2% | -56,6 k € | -285.4% | 30,5 k € | -36.8% | 48,3 k € | -38.4% | 78,4 k € | +444.2% | 14,4 k € | -68.2% | 45,4 k € | -52.2% | 95,0 k € | -9.8% | 105,3 k € | +3.4% | 101,8 k € | -10.2% | 113,4 k € | -3.8% | 117,9 k € | +35.0% | 87,3 k € | +25.4% | 69,7 k € | +235.2% | -51,5 k € | -491.3% | 13,2 k € | +118.2% | -72,1 k € | -97.2% | -36,6 k € | +64.2% | -102,1 k € | |
| Equity | 625,3 k € | -11.8% | 709,2 k € | -7.4% | 765,9 k € | +4.2% | 735,3 k € | +7.0% | 687,0 k € | +12.9% | 608,6 k € | +24.0% | 490,7 k € | +10.2% | 445,3 k € | +27.1% | 350,4 k € | +42.9% | 245,1 k € | +71.0% | 143,3 k € | +259.2% | 39,9 k € | +154.6% | -73,1 k € | +54.5% | -160,4 k € | +30.3% | -230,1 k € | -28.8% | -178,6 k € | +6.9% | -191,7 k € | -60.3% | -119,6 k € | -44.0% | -83,0 k € | |
| Total assets | 1,3 M € | +38.4% | 917,7 k € | +10.4% | 831,0 k € | -0.1% | 831,8 k € | +2.0% | 815,4 k € | -16.4% | 975,4 k € | +3.6% | 941,8 k € | -4.6% | 987,4 k € | -3.8% | 1,0 M € | +7.8% | 951,7 k € | +10.4% | 861,7 k € | +17.6% | 732,7 k € | +7.2% | 683,3 k € | +12.3% | 608,4 k € | -5.6% | 644,6 k € | -14.6% | 754,5 k € | -12.3% | 860,2 k € | -6.5% | 919,9 k € | -11.4% | 1,0 M € | |
| Cash | 136,6 k € | +236.5% | 40,6 k € | -84.0% | 253,9 k € | +22.6% | 207,2 k € | +9.2% | 189,7 k € | +68.0% | 112,9 k € | +2554.0% | 4,3 k € | +25.2% | 3,4 k € | -81.6% | 18,5 k € | +73.4% | 10,7 k € | -18.0% | 13,0 k € | -25.3% | 17,4 k € | +55.0% | 11,2 k € | -7.3% | 12,1 k € | +27.8% | 9,5 k € | +1480.5% | 600,0 € | -97.0% | 20,1 k € | +584.2% | 2,9 k € | -27.3% | 4,0 k € | |
| Debts | 644,4 k € | +209.2% | 208,4 k € | +220.2% | 65,1 k € | -32.6% | 96,5 k € | -24.8% | 128,4 k € | -65.0% | 366,8 k € | -18.7% | 451,1 k € | -16.8% | 542,0 k € | -19.8% | 676,0 k € | -4.3% | 706,6 k € | -1.6% | 718,3 k € | +3.7% | 692,8 k € | -8.3% | 755,7 k € | -1.7% | 768,8 k € | -11.9% | 872,4 k € | -6.5% | 933,1 k € | -11.0% | 1,0 M € | +0.9% | 1,0 M € | -7.3% | 1,1 M € | |
| Staff | — | — | — | — | — | 3 | 2,8 | 2,2 | 2,1 | 2,6 | 2,3 | 1,9 | 1,9 | 2 | 1,9 | 1,9 | 1,9 | 1,4 | 2,1 | |||||||||||||||||||
Private limited company · Frameries · incorporated on 27/12/2002
Private limited company loss-making in the latest fiscal year. Cash position rising (+236.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
PHARMACIE FAIDHERBE is a Private limited company incorporated in 2002. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette